Product image of Zynlonta (Loncastuximab Tesirine) supplied by GNH India

Zynlonta

Active Ingredient:
Loncastuximab Tesirine
Origin:
EU

Zynlonta (Loncastuximab Tesirine)

Zynlonta (loncastuximab tesirine) is an intravenous therapy for relapsed or refractory large B-cell lymphoma. This CD19-directed antibody and alkylating agent targets cancer cells. It is prescribed when prior treatments have not succeeded. Always consult a healthcare provider for suitability.

Manufacturer / TM Owner

Swedish Orphan Biovitrum Ab (Publ)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zynlonta is used to treat adults with relapsed or refractory large B-cell lymphoma after at least two prior therapies. It targets CD19-positive cancer cells, helping to slow disease progression. This medication is typically considered when standard treatments have not been effective. It is administered under medical supervision in clinical settings.

Side Effects

  • Zynlonta works by binding to cancer cells and delivering a cytotoxic agent to reduce tumor size. Patients may experience changes in blood cell counts due to its effects on rapidly dividing cells. Regular monitoring is recommended to track response and manage potential changes in health status.

Precautions & Warnings

  • Zynlonta is given by healthcare professionals in a controlled environment due to its potent effects. Patients should report any new or worsening symptoms, including infections or unusual bleeding. Avoid close contact with individuals who are sick during treatment. Keep all scheduled appointments for blood tests and evaluations.

Avoid Interactions

  • Drug interactions with Zynlonta are not fully established, but caution is advised with other medications that affect the immune system or blood cell counts. Alcohol and certain supplements may increase side effects. Always inform your provider about all medications and supplements being taken before starting treatment.

Frequently Asked Questions

Zynlonta is used to treat adults with relapsed or refractory large B-cell lymphoma after at least two prior therapies.

Zynlonta is given as an intravenous infusion in a healthcare setting by trained professionals.

Common side effects may include changes in blood cell counts, infections, or fatigue. Regular monitoring helps manage these effects.

Always inform your healthcare provider about all medications and supplements before starting Zynlonta to assess potential interactions.

Zynlonta is a targeted therapy that combines an antibody with a cytotoxic agent, similar in concept to some chemotherapy approaches.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Loncastuximab Tesirine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT